Background and aims: To evaluate the prognostic value of the combined assessment of hemoglobin glycation index (HGI) and stress hyperglycemia ratio (SHR) for short-term mortality in critically ill patients with heart failure (HF).
Methods and results: ICU data on HF patients were retrospectively retrieved from the MIMIC-III and IV databases between 2001 and 2022. SHR and HGI were calculated at admission and stratified into tertiles. The endpoint was in-hospital and 90-day mortality. Logistic and Cox models evaluated associations between SHR, HGI, and their combination with mortality in both diabetic and non-diabetic patients. Exploratory interpretable machine learning prognostic models were developed to evaluate predictive performance. A total of 1573 HF patients were included. In-hospital and 90-day mortality rates were 14.1% and 24.3%, respectively. High SHR was independently associated with increased in-hospital mortality (OR: 2.01, 95% CI: 1.31-3.09) and 90-day mortality (HR: 1.54, 95% CI: 1.18-2.00). Higher HGI was associated with a reduced risk of in-hospital mortality (OR: 0.88, 95% CI: 0.78-0.99) and 90-day mortality (HR: 0.91, 95% CI: 0.84-0.98). High SHR and low HGI had the highest mortality risk for both in-hospital mortality (OR: 1.90, 95% CI: 1.288-2.85) and 90-day mortality (HR: 1.45, 95% CI: 1.13-1.87). The XGBoost model demonstrated optimal predictive accuracy, with an AUROC of 0.810 for in-hospital mortality and 0.808 for 90-day mortality.
Conclusion: High SHR and low HGI are significantly associated with short-term mortality in HF patients, suggesting that their combined assessment may improve short-term prognostic assessment in critically ill patients with HF.
Keywords: Diabetes; Heart failure; Hemoglobin glycation index; Mortality; Stress hyperglycemia ratio.
Copyright © 2026 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.